Congenital absence of the fibrin-stabilizing factor. (Factor 13)
Ciepielewska, D.; Lopaciuk, S.
Pediatria Polska 45(7): 829-832
1970
ISSN/ISBN: 0031-3939 PMID: 5449789 Document Number: 30555
Document emailed within 1 workday
Related Documents
Hung, I.J. 1980: Congenital deficiency of fibrin-stabilizing factor (factor XIII) Journal of the Formosan Medical Association 79(11): 1025-1031Aguercif, M.; Nigg, O.M.; Lopez, J.M.; Bouvier, C.A. 1971: Congenital deficiency of fibrin stabilizing activity. Presence of a protein immunologically analogous to factor XIIi Nouvelle Revue Francaise d'Hematologie 11(6): 841-848
Boda, Z.; Muszbek, L.; Hársfalvi, J.; Tóth, A.; Pfliegler, G.; Tornai, I.; Rák, K. 1988: A case of FXIIi (fibrin stabilizing factor, Laki-Lóránd factor) deficiency Orvosi Hetilap 129(41): 2199-2202
Rossi, A.; Argenziano, G. 1970: Factor XIIi (fibrin stabilizing factor) in various dermatological diseases (screening test) Archives d'Anatomie Microscopique et de Morphologie Experimentale 59(2): 198-201
Kloczko, J.; Zuch, A.; Bielawiec, M.; Buluk, K. 1980: Factor XIIi (FSF - fibrin stabilizing factor) in pathological states with thrombin generation Haematologica 65(5): 629-635
Kłoczko, J.; Zuch, A.; Bielawiec, M.; Buluk, K. 1983: Activity of fibrin stabilizing factor (FSF; factor XIII) in lymphoproliferative disorders Acta Haematologica Polonica 14(1): 13-19
Brandt, M.; Hofmann, K.D.; Wagner, F.; Koob, P. 1978: Effect of hormonal contraception on the fibrin-stabilizing factor (factor XIII) Zentralblatt für Gynakologie 100(17): 1089-1092
Zuch, A.; Rudobielska, M.; Zwierzowa, W.; Jurgielewicz, E.; Buluk, K. 1972: Ontogenetic variability of fibrin stabilizing factor level (FSF--Factor XIII of blood coagulation system) in the plasma of healthy children Pediatria Polska 47(10): 1197-1203
Bohn, H.; Schwick, H.G. 1971: Isolation and characterization of a fibrin-stabilizing factor from human placenta Arzneimittel-Forschung 21(10): 1432-1439
Turovets, I.G.; Vovk, B.E.; Korvatskii, B.G.; Khomenko, D.G.; Latypova, L.S. 1972: Fibrin-stabilizing factor XIII, fibrinase, and its importance in the surgical clinic Klinicheskaia Khirurgiia 1(11): 50-54
Vogel, C. 1980: Behavior of the fibrin-stabilizing blood coagulation factor XIIi in hemorrhages after tooth extractions Deutsche Zahnarztliche Zeitschrift 35(1): 137-138
Hoffmann, K.J.; Ljunggren, C.; Stenberg, P.; Nilsson, J.L. 1973: Fibrin-stabilizing factor inhibitors. IX. An inhibitor assay method based on SDS-disc gel electrophoresis Acta Pharmaceutica Suecica 10(4): 269-276
Zuch, A.; Buluk, K. 1980: Impairment of the desmofibrinogenic activity of the fibrin stabilizing factor (FSF) due to free thiol group (SH) deficiency in middle-aged and old persons Acta Haematologica Polonica 11(3): 129-135
España, F.; Ratnoff, O.D. 1983: Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases Journal of Laboratory and Clinical Medicine 102(1): 31-45
Hooper, W.C.; Dilley, A.; Austin, H.; Wenger, N.K.; Benson, J.; Evatt, B.L.; Silva, V.; Rawlins, P. 1998: Absence of mutations at APC cleavage sites Arg306 in factor V and Arg336, Arg562 in factor VIII in African-Americans Thrombosis and Haemostasis 79(1): 236
Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59
Fu, Q.-h.; Wang, H.-l.; Wang, M.-s.; Ding, Q.-l.; Wu, W.-m.; Hu, Y.-q.; Wang, X.-f.; Wang, Z.-y. 2003: Two novel factor V gene mutations associated with congenital coagulation factor V deficiency, study of one pedigree Zhonghua Yi Xue Za Zhi 83(4): 312-315
Bérubé, C.; Ofosu, F.A.; Kelton, J.G.; Blajchman, M.A. 1992: A novel congenital haemostatic defect: combined factor VIi and factor Xi deficiency Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 3(4): 357-360
Schricker, K.T.; Neidhardt, B. 1981: Gastrectomy in congenital factor VIi deficiency with substitution of factor VIi concentrate Medizinische Klinik 76(19): 534-536
Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87